期刊
GENE THERAPY
卷 16, 期 10, 页码 1189-1201出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/gt.2009.81
关键词
allosteric; aptamer; directed evolution; riboswitch; ribozyme; RNA switch
类别
资金
- Howard Hughes Medical Institute
- NSF
- NIH
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068819] Funding Source: NIH RePORTER
In the last two decades, remarkable advances have been made in the development of technologies used to engineer new aptamers and ribozymes. This has encouraged interest among researchers who seek to create new types of gene-control systems that can be made to respond specifically to small-molecule signals. Validation of the fact that RNA molecules can exhibit the characteristics needed to serve as precision genetic switches has come from the discovery of numerous classes of natural ligand-sensing RNAs called riboswitches. Although a great deal of progress has been made toward engineering useful designer riboswitches, considerable advances are needed before the performance characteristics of these RNAs match those of protein systems that have been co-opted to regulate gene expression. In this review, we will evaluate the potential for engineered RNAs to regulate gene expression and lay out possible paths to designer riboswitches based on currently available technologies. Furthermore, we will discuss some technical advances that would empower RNA engineers who seek to make routine the production of designer riboswitches that can function in eukaryotes. Gene Therapy (2009) 16, 1189-1201; doi: 10.1038/gt.2009.81; published online 9 July 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据